ASX:CURE

ETFS S&P Biotech ETF Stock Forecast, Price & News

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume2,243 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive CURE News and Ratings via Email

Sign-up to receive the latest news and ratings for ETFS S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Headlines

ETFS S&P Biotech ETF (CURE.AX)
October 21, 2021 | au.finance.yahoo.com

HNF collaborates with Rarebase on a Drug Discovery Platform to develop treatments for Charcot-Marie-Tooth (CMT)
October 14, 2021 | markets.businessinsider.com

Shares for the Cure: Simplify Introduces Health Care ETF Benefiting Susan G. Komen
October 10, 2021 | finance.yahoo.com

With Early and Effective Treatment Retinoblastoma in Children Can Have a 96% Success Rate
September 19, 2021 | benzinga.com

COVID-19 Scoop: Epoch-Making GoldenBiotech's Oral COVID-19 New Drug Trial Got Green Light from the FDA to Extend Recruiting Severe COVID-19 Patients
September 17, 2021 | markets.businessinsider.com

Rarebase launches a neuroscience drug discovery platform collaborating with 15 rare disease patient organizations
September 16, 2021 | markets.businessinsider.com

This 28% Short Biotech Company Has A Better 1-Year Return Than AMC, Snap, Apple And Tesla
September 7, 2021 | markets.businessinsider.com

ETFS S&P Biotech ETF
August 11, 2021 | barrons.com

Cathie Wood's Ark ETFs are surging on big gains in CRISPR gene-editing stocks following the success of first human trials
June 28, 2021 | msn.com

6 ETFs For Adding A 7% Yield To Your Portfolio Today
June 16, 2021 | thestreet.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: N/A
Sub-Industry: N/A
Sector: N/A
Current Symbol: ASX:CURE
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: N/A
Phone: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Optionable

MarketRank^™

Overall MarketRank^™

1.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for ETFS S&P Biotech ETF.

5.0 Community Rank

Outperform Votes
ETFS S&P Biotech ETF has received 3 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
ETFS S&P Biotech ETF has received 0 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
ETFS S&P Biotech ETF has received 100.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about ETFS S&P Biotech ETF and other stocks. Vote “Outperform” if you believe CURE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CURE will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
ETFS S&P Biotech ETF does not currently pay a dividend.
Dividend Growth
ETFS S&P Biotech ETF does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ETFS S&P Biotech ETF insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

ETFS S&P Biotech ETF (ASX:CURE) Frequently Asked Questions

What stocks does MarketBeat like better than ETFS S&P Biotech ETF?: Wall Street analysts have given ETFS S&P Biotech ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ETFS S&P Biotech ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
How often does ETFS S&P Biotech ETF pay dividends? What is the dividend yield for ETFS S&P Biotech ETF?: ETFS S&P Biotech ETF declared a Final dividend on Friday, June 25th. Shareholders of record on Wednesday, July 14th will be given a dividend of 5.8631 per share on Wednesday, July 14th. This represents a yield of 8.56%. The ex-dividend date is Tuesday, June 29th. This is a positive change from ETFS S&P Biotech ETF's previous Final dividend of A$0.04.
View ETFS S&P Biotech ETF's dividend history.
What is ETFS S&P Biotech ETF's stock symbol?: ETFS S&P Biotech ETF trades on the ASX under the ticker symbol "CURE."

This page was last updated on 10/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.